Announcement
1cBio and Alesta Therapeutics Sign Global Deal to Develop a First-in-Class Small Molecule Treatment for Hypophosphatasia
1cBio
PR-01-25-NI-04Jan 08, 2025
CDMO
Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites
Mikart
PR-10-24-NI-54Oct 22, 2024
Nice Insight API Report
Small Molecule API Discovery and Development Trends
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-01Mar 21, 2024
Business Leadership
Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division
Olon
PR-M09-22-04Sep 19, 2022
Drug Discovery
Enabling Seamless Workflows for Small Molecule Drug Discovery
Melanie Nelson, Ph.D.
Dotmatics
PAO-08-022-CL-08Aug 23, 2022
R&D Data Management
Dotmatics Launches Small Molecule Drug Discovery Solution Helping Researchers Accelerate Life-Improving Therapies
Dotmatics
PR-M07-22-05Jul 19, 2022
API
Small Molecule API Market Trends
James Grote
Nice Insight
PAO-06-022--NI-11Jun 24, 2022
mRNA
The Intersection of mRNA Biology and Artificial Intelligence is Yielding Unique mRNA Drug Candidates
Yochi Slonim
Anima Biotech Inc.
PAO-04-022-CL-14May 05, 2022
Solubility
The Limitless Potential of Thin Film Freezing
Glenn Mattes
TFF Pharmaceuticals, Inc.
PAO-01-22-CL-04Mar 12, 2022
Oncology
Fighting Cancer by Focusing on Nuclear Export
Richard Paulson
PAO-02-022-CL-06Mar 12, 2022
Parenteral Drugs
A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects
Marga Viñes; Oriol Prat; Oriol Argemi
Grifols
PAO-12-21-CL-02Dec 13, 2021
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
Marko Salo; Arne Grumann
Fermion
PAO-09-21-CL-05Sep 16, 2021
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
Pierre Luzeau, Ph.D.
Seqens
PAP-Q4-20-CL-025Dec 09, 2020
Small Molecule API
Supporting Client Projects for CDMO Success
Marc Sauer, Ph.D.; Mark Wellman
BIOVECTRA
PAP-Q1-2019-CL-030Mar 12, 2019
Oncology
Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors
Regen BioPharma Inc.
PR-M11-18-NI-048Nov 14, 2018
Designation
Prometic receives Rare Pediatric Disease Designation from U.S. FDA for small molecule drug candidate, PBI-4050
Prometic
PR-M08-18-NI-068Aug 16, 2018
Business
Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases
Expansion Therapeutics, Inc.
PR-M01-18-NI-009Jan 03, 2018
NIH Funds Novel Small Molecule Approach to Interrupt Alzheimer’s Dementia
Nigel Walker
Nice Insight
PAO-M10-17-NI-003Oct 03, 2017
Innovation
New Technology Allows Imaging of Complex Molecular Processes
Emilie Branch
Pharma's Almanac
PAO-M06-17-NI-023Jun 29, 2017
Growth Anticipated for Intermediates
Steve Kuehn; Emilie Branch; Nice Insight; Carrie Cao, Ph.D.
Nice Insight
PAP-Q1-17-FA-005Mar 08, 2017